NeuroOne Medical Technologies Corporation (NMTC) Gross profit 2021–2025
NeuroOne Medical Technologies Corporation (NMTC) annual gross profit history from SEC filings — each fiscal year as reported.
$5.1MFY2025 · since FY2021: -$97,749 → $5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.1M | +376.2% |
| FY2024 | $1.1M | +136.5% |
| FY2023 | $456,517 | +744.9% |
| FY2022 | -$70,794 | +27.6% |
| FY2021 | -$97,749 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Net marginNMTC Gross marginNMTC Operating incomeNMTC Operating marginNMTC Operating cash flowNMTC Free cash flowNMTC Capital expendituresNMTC Return on equityNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →